AI assistant
Sending…
Glucotrack, Inc. — Director's Dealing 2024
Apr 25, 2024
35378_dirs_2024-04-24_951724c5-114f-42e0-b110-63efd35701bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GlucoTrack, Inc. (GCTK)
CIK: 0001506983
Period of Report: 2024-04-22
Reporting Person: Goode Paul (Chief Executive Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 398819.52 | Direct |
Footnotes
F1: Ownership includes (i) 101,950 shares of Common Stock owned individually and (ii) 273,060 Options deemed vested within 60 days of March 28, 2024, both owned as of March 28, 2024, and (ii) 23,809.52 shares acquired on April 22, 2024 at a price per share of $1.26.
More from Glucotrack, Inc.
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 14
Annual Report
2026
Mar 30
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Proxy Solicitation & Information Statement
2026
Feb 9
Regulatory Filings
2026
Jan 29